SOPHiA GENETICS S.A. (SOPH)
SOPHiA GENETICS S.A. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Rolle, VD, CH. The stock last traded at $7.49, down 1.61% on the session, giving a market capitalisation of $628.1M. On trailing twelve-month figures it carries a trailing P/E of -6.51, a net margin of -93.9%. Its beta of 0.92 implies it has historically moved less than the broad market.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
SOPHiA GENETICS S.A. is most often compared with the following Healthcare names: